Cargando…
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
Myeloma is characterized by a highly variable clinical outcome. Despite the effectiveness of high-dose therapy, 15% of patients relapse within 1 year. We show that these cases also have a significantly shorter post-relapse survival compared to the others (median 14.9 months vs. 40 months, p = 8.03 ×...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444991/ https://www.ncbi.nlm.nih.gov/pubmed/24913504 http://dx.doi.org/10.3109/10428194.2014.911863 |